Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registry
about
A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?Predictors and persistence of new-onset clinical remission in rheumatoid arthritis patients.Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period.MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial.Serological and Progression Differences of Joint Destruction in the Wrist and the Feet in Rheumatoid Arthritis - A Cross-Sectional Cohort Study.Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients.Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugsAnaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study.What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review.anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab.Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis Factor.Two-year radiographic and clinical outcomes from the Canadian Methotrexate and Etanercept Outcome study in patients with rheumatoid arthritis.Guidelines for the drug treatment of rheumatoid arthritis.The good EULAR response at the first year is strongly predictive of clinical remission in rheumatoid arthritis: results from the TARAC cohort.A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis.Association of weight loss with improved disease activity in patients with rheumatoid arthritis: A retrospective analysis using electronic medical record data.
P2860
Q33840415-179735FE-7C0D-4022-A958-2473E147B29AQ34285092-5198689F-7EC9-4D44-9DC7-270041F5D389Q34818608-694DFB7B-4565-4C61-84C3-A5F196F12A1AQ35605418-2B56590A-1C91-4BA9-9898-B1875FD1F492Q35759047-F0D1F899-489F-40AF-BA92-F715DEF80114Q36706945-8527252B-2EAA-4289-8002-FF3EE8F778D9Q37085663-AC651AF1-685B-4D05-BE45-5DB7E7F344CEQ37658783-D5B5CF5E-58F6-436F-83FE-7197C05A3391Q38097740-A99455C4-1871-4726-AE9A-8828CBC72E30Q38207759-58D5DAC5-A742-4AFE-AB8D-A1B1490EF38DQ38937827-D0B0BA95-79FA-40A9-9308-EFE847557C11Q40548376-DFE39097-B807-4AD3-8CC8-31EE279B65D8Q43675571-127F4A19-0971-40CB-9BF3-7F34AFA66B0EQ46081724-899895AD-27CE-4B5E-BACD-75765545C85CQ47755963-9369FACA-B86C-416F-9F28-5D8A890889ACQ55563232-B09DFEB2-2148-4F4C-94F5-8CCD56594CE6
P2860
Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registry
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Greater likelihood of remissio ...... hers of North America registry
@ast
Greater likelihood of remissio ...... hers of North America registry
@en
type
label
Greater likelihood of remissio ...... hers of North America registry
@ast
Greater likelihood of remissio ...... hers of North America registry
@en
prefLabel
Greater likelihood of remissio ...... hers of North America registry
@ast
Greater likelihood of remissio ...... hers of North America registry
@en
P2093
P2860
P356
P1476
Greater likelihood of remissio ...... hers of North America registry
@en
P2093
Aileen L Pangan
Daniel E Furst
George Reed
Hong Chang
Jeffrey D Greenberg
Joel M Kremer
Leslie R Harrold
P2860
P304
P356
10.1002/ACR.20452
P577
2011-06-01T00:00:00Z